Tag Archives: Conduit Pharmaceuticals

Conduit Pharmaceuticals executive sells over $4.5 million in stock, a move that has sent ripples through the financial world. This significant transaction raises questions about the executive’s motivations, the potential impact on the company’s future, and the implications for investors. The sale, occurring amidst a backdrop of fluctuating market conditions …

Read More »